Balyasny Asset Management LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $1.5 Million - $1.82 Million	1,700 Added 283.33%	2,300 $2.42 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $541,614 - $596,010	600 New	600 $577,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $70,589 - $76,639	-100 Reduced 1.75%	5,600 $4.04 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $2.47 Million - $3.11 Million	4,300 Added 307.14%	5,700 $3.93 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $767,690 - $1.03 Million	1,400 New	1,400 $828,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $15.7 Million - $18.7 Million	-27,400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $13 Million - $15.3 Million	27,400 New	27,400 $15.3 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $47.8 Million - $60.8 Million	-100,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $54.5 Million - $65.8 Million	100,000 New	100,000 $56 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $37 Million - $50.8 Million	-135,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $9.57 Million - $11.1 Million	35,000 Added 35.0%	135,000 $37.4 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $18.9 Million - $26.1 Million	63,000 Added 170.27%	100,000 $32 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $25.5 Million - $30.1 Million	-68,500 Reduced 64.93%	37,000 $15.2 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $13.7 Million - $15.9 Million	39,000 Added 58.65%	105,500 $40.5 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $12.1 Million - $14.7 Million	-42,500 Reduced 38.99%	66,500 $22.9 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $12.2 Million - $15.2 Million	-38,500 Reduced 26.1%	109,000 $37.5 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $52.9 Million - $69.3 Million	147,500	147,500 $55.5 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$9.37 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$8.8 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$8.63 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$5.05 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$4.83 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account